Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Tigris Series A Gets $11.6M For Topical Product In HPV

Oct. 17, 2005

By Jennifer Boggs

Koronis Working To Kill HIV By Increasing Viral Mutations

Oct. 14, 2005

By Jennifer Boggs

Koronis Working To Kill HIV By Increasing Viral Mutations

Oct. 14, 2005

By Jennifer Boggs

Raven's Series D: $48M For RAV12 Cancer Trials

Oct. 13, 2005

By Jennifer Boggs

Raven's Series D: $48M For RAV12 Cancer Trials

Oct. 13, 2005

By Jennifer Boggs

Praecis Continues Cost-Cutting Efforts, Sells Research Facility

Oct. 12, 2005

By Jennifer Boggs

CepTor Adding $20M To Test Myodur In Muscular Dystrophy

Oct. 12, 2005

By Jennifer Boggs

CepTor Adding $20M To Test Myodur In Muscular Dystrophy

Oct. 12, 2005

By Jennifer Boggs

Praecis Continues Cost-Cutting Efforts, Sells Research Facility

Oct. 12, 2005

By Jennifer Boggs

Vasogen Adds $40M Through Notes Sale For Celacade Work

Oct. 11, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 23, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.